Viewing Study NCT04707547



Ignite Creation Date: 2024-05-06 @ 3:39 PM
Last Modification Date: 2024-10-26 @ 1:54 PM
Study NCT ID: NCT04707547
Status: COMPLETED
Last Update Posted: 2021-01-13
First Post: 2020-12-16

Brief Title: Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation RFA Therapy
Sponsor: Taipei Medical University WanFang Hospital
Organization: Taipei Medical University WanFang Hospital

Study Overview

Official Title: Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation RFA Therapy
Status: COMPLETED
Status Verified Date: 2020-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RFA
Brief Summary: Clearing potential intrahepatic metastasis to prevent early recurrence after liver cancer treatment there are no effective interventions so far For secondary metastatic cancer only the lesions visible under ultrasound can be used one by one for local ablation and chemotherapy but people may develop new tumor lesions Therefore the treatment of potential tumors and recurrent tumors after ablation is a very important clinical issue
Detailed Description: Clearing potential intrahepatic metastasis to prevent early recurrence after liver cancer treatment there are no effective interventions so far For secondary metastatic cancer only the lesions visible under ultrasound can be used one by one for local ablation and chemotherapy but people may develop new tumor lesions Therefore the treatment of potential tumors and recurrent tumors after ablation is a very important clinical issue Therefore this study will include primary liver cancer as well as secondary metastatic malignant liver cancer such as colorectal cancer lung cancer breast cancer and other cancers with a high incidence in Chinese patients and detection of immune cells by surgery and through various biomarkers to explore its mechanism and efficacy

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: None